<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-0ZYIH95W</identifier><date>2013</date><creator>Černelč, Peter</creator><creator>Gržinič, Neda</creator><creator>Podgornik, Helena</creator><relation>documents/doc/0/URN_NBN_SI_doc-0ZYIH95W_001.htm</relation><relation>documents/doc/0/URN_NBN_SI_doc-0ZYIH95W_001.pdf</relation><relation>documents/doc/0/URN_NBN_SI_doc-0ZYIH95W_001.txt</relation><format format_type="issue">5</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 354-362</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="URN">0014-8229</identifier><identifier identifier_type="COBISSID">27314983</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">drug</subject><subject language_type_id="slv">kronična limfatična levkemija</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravila</subject><subject language_type_id="slv">zdravljenje</subject><title>Chronic lymphocytic leukemia</title><title>Kronična limfatična levkemija</title></Record>